Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

McMaster University

$150,000.00

Investigating the use of Phage Therapy for the Treatment of Colitis in a Pathobiont-Driven Gnotobiotic Mouse Model

FY 2021-22

Summary
The proportion of Canadians suffering from chronic bowel inflammation is alarmingly increasing. One condition, termed "inflammatory bowel disease" (IBD) is particularly debilitating, affecting young and ageing populations. One driver of such inflammation, or "colitis", is the presence of harmful bacteria in the digestive tract. Antibiotics have been previously used, but they are not selective and can cause more problems by disturbing the community of microbes ("microbiota") that inhabits the gut, resulting in secondary infections. Solutions that selectively target these harmful bacterial, while avoiding perturbation of beneficial microbiota, are needed. The solution we propose is to use good viruses known as "bacteriophages" or "phages", which only infect bacteria and not human cells. Phages target specific bacteria and can knock out one type of bacteria in a mixed population while leaving the others intact. In that sense, phages are like guided missiles; they only attack their assigned targets. Previous work in our lab has confirmed that phages do not cause inflammation when present in the digestive tract nor do they impact the healthy bacteria already there. To understand how phages can help cure gut inflammation, we propose investigate their action in a colitis model driven by harmful bacteria isolated from the gut of patients with IBD. The model is directly relevant to human disease, and will provide the basis required to develop phages into an applicable therapeutic treatment for humans who suffer from IBD. The knowledge produced in this project could lead to the development of an effective cure that will directly impact the lives of 270,000 Canadians living with IBD.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
457468
Name
Jackson Kyle E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Investigating the use of Phage Therapy for the Treatment of Colitis in a Pathobiont-Driven Gnotobiotic Mouse Model
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Bacteriophage; Bioengineering; Biofilms; Biotechnology; Colitis; Escherichia Coli; Gnotobiotic Mouse Model; Inflammatory Bowel Disease; Mucosal Immunology; Phage Therapy
Abstract
The proportion of Canadians suffering from chronic bowel inflammation is alarmingly increasing. One condition, termed "inflammatory bowel disease" (IBD) is particularly debilitating, affecting young and ageing populations. One driver of such inflammation, or "colitis", is the presence of harmful bacteria in the digestive tract. Antibiotics have been previously used, but they are not selective and can cause more problems by disturbing the community of microbes ("microbiota") that inhabits the gut, resulting in secondary infections. Solutions that selectively target these harmful bacterial, while avoiding perturbation of beneficial microbiota, are needed. The solution we propose is to use good viruses known as "bacteriophages" or "phages", which only infect bacteria and not human cells. Phages target specific bacteria and can knock out one type of bacteria in a mixed population while leaving the others intact. In that sense, phages are like guided missiles; they only attack their assigned targets. Previous work in our lab has confirmed that phages do not cause inflammation when present in the digestive tract nor do they impact the healthy bacteria already there. To understand how phages can help cure gut inflammation, we propose investigate their action in a colitis model driven by harmful bacteria isolated from the gut of patients with IBD. The model is directly relevant to human disease, and will provide the basis required to develop phages into an applicable therapeutic treatment for humans who suffer from IBD. The knowledge produced in this project could lead to the development of an effective cure that will directly impact the lives of 270,000 Canadians living with IBD.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Jackson, Kyle E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
McMaster University - $150,000 Grant (2021-22) | Canada Spends